Status:
RECRUITING
Vitaccess Real MG Registry
Lead Sponsor:
Vitaccess Ltd
Conditions:
Myasthenia Gravis
Eligibility:
All Genders
18+ years
Brief Summary
Vitaccess Real MG (VRMG) is a patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of li...
Detailed Description
Traditional site recruitment (all countries): Adult patients who are being treated for MG at one of the participating clinics or centers in one of the participating countries (currently the US and UK...
Eligibility Criteria
Inclusion
- Adult (age ≥18 years) with a clinically-confirmed diagnosis of myasthenia gravis (MG).
- Resident in one of the scope countries.
- Access to a smartphone/tablet/computer/laptop
- Willing and able to provide informed consent in their local language to take part in the study.
Exclusion
- Participation in a clinical trial at the time of study enrolment.
Key Trial Info
Start Date :
July 31 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2034
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06064461
Start Date
July 31 2024
End Date
July 1 2034
Last Update
July 29 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
UCI Health
Orange, California, United States, 92868
2
HSHS St. Elizabeth's Hospital
O'Fallon, Illinois, United States, 62269
3
UK HealthCare - University of Kentucky
Lexington, Kentucky, United States, 40536
4
Neurology Associates of South Jersey
Lumberton, New Jersey, United States, 08048